JNJ vs WMT: Which Is the Better Buy?
Side-by-side comparison of Johnson & Johnson and Walmart Inc. — fair value, conviction, valuation metrics, and QuantHub research signals.
Updated 2026-09-25.
Johnson & Johnson · Healthcare
$270.68
+5.7% upside to fair value
Med Conviction
Grade C
High Quality
VS
Walmart Inc. · Consumer Defensive
$106.73
-10.8% upside to fair value
Med Conviction
Grade C
High Quality
QuantHub Verdict
JNJ has more upside to fair value
(+5.7%).
These are model outputs — not personalized investment advice.
See all research →
Valuation & Fundamentals
| Metric |
JNJ |
WMT |
| Current Price |
$270.68 |
$106.73 |
| Fair Value Estimate |
$286.05 |
$95.24 |
| Upside to Fair Value |
+5.7%
|
-10.8%
|
| Market Cap |
$652.3B |
$849.4B |
| Forward P/E |
—
|
—
|
| EV / EBITDA |
20.2x
|
21.3x
|
| Price / Sales |
6.7x
|
1.1x
|
| Price / FCF |
35.3x
|
62.8x
|
| Revenue Growth YoY |
+6.6%
|
+5.9%
|
| Gross Margin |
67.9%
|
25.2%
|
| Operating Margin |
26.8%
|
4.4%
|
| Return on Equity |
25.7%
|
22.7%
|
| Dividend Yield |
1.95% |
0.92% |
| FCF Yield |
2.83%
|
1.59%
|
| Analyst Consensus |
Buy
|
Strong Buy
|
Investment Thesis
Johnson & Johnson is a 141,700-employee healthcare holding company operating two segments, Innovative Medicine (immunology, oncology, neuroscience, infectious disease, cardiovascular and metabolism, pulmonary hypertension) and MedTech (interventional solutions, orthopaedics, surgery, vision), founded in 1887 and headquartered in New Brunswick, New Jersey. Business quality is high on fundamentals:…
Walmart Inc. is the world's largest retailer by revenue, operating more than 10,000 stores and clubs across Walmart U.S., Walmart International, and Sam's Club, with a fast-growing e-commerce and advertising ecosystem layered on top of a grocery-led, everyday-low-price model. The business quality is high: scale and sourcing power underpin a durable cost advantage, ROE is 22.7%, and revenue grew 5…
Accumulation Zones
| Metric |
JNJ |
WMT |
| Zone Low |
$214.54 |
$71.43 |
| Zone High |
$243.14 |
$80.95 |
| In Buy Zone? |
No
|
No
|